Biography
Biography: Thomas Ryzlewicz
Abstract
The worldwide use of acidification with 3 mmol/L of acetate is critical, as there is a big problem of calcification. The majorityrnof the CKD-5 patients has own big problems with calcification. After each Dialysis it is necessary to descale the monitor.rnOnly the patient never will be descaled. To elevate the dosage of acetate is no good idea as the production of CO2 becomesrnbigger. This is a problem for cold patients as well as for patients weaning from the respirator. The alternative prescription withrn1 mmol/L citrate has the same amount of CO2 production as 3 mmol/L acetate but the dialysis fluid with citrate never has arnproblem of calcification. There is a second principle of working, the chelate binding of the two problems ions Ca++ and Mg++.rnUnfortunately, this essential problem will not well understand by the doctors and by the FDA Department, medical productsrnas it is a problem of chemical solubility. Dialysis concentrate is a medical product and so there is no follow-up concerning thisrncalcification problem. First target is to reach a chemical evaluation; second target is the prohibition of dialysis concentrate byrn3 mmol/L acetate.
